GLOBAL DRUG SURVEY LIMITED

(Company Number 07534181)

Registered office: 14 Amherst Avenue, London, W13 8NQ

Principal trading address: 14 Amherst Avenue, London, W13 8NQ

Notice is hereby given that Creditors of the Company are required, on or before 27 March 2026, to prove their debts by delivering their proofs (in the format specified in Rule 14.4 of the Insolvency (England and Wales) Rules 2016) to the Joint Liquidators at Clarke Bell Limited, 3rd Floor, The Pinnacle, 73 King Street, Manchester, M2 4NG.

If so required by notice from the Joint Liquidators, creditors must produce any document or other evidence which the Joint Liquidators consider is necessary to substantiate the whole or any part of a claim.

Note: The Directors of the Company have made a declaration of solvency and it is expected that all creditors will be paid in full.

Date of Appointment: 24 February 2026.

Office Holder Details: John Paul Bell (IP No. 8608) and Toyah Marie Poole (IP No. 9740) both of Clarke Bell Limited, 3rd Floor, The Pinnacle, 73 King Street, Manchester, M2 4NG

For further details contact: The Joint Liquidators, Email: mvl@clarkebell.com. Alternative contact: Caolan Keegan.

John Paul Bell, Joint Liquidator

3 March 2026

Ag NK120298